{"id":"https://openalex.org/W2014909757","doi":"https://doi.org/10.1111/j.1755-3768.2012.3682.x","title":"Valproic acid (VPA), a class I and II histone deacetylase (HDAC) inhibitor and conjunctival melanoma","display_name":"Valproic acid (VPA), a class I and II histone deacetylase (HDAC) inhibitor and conjunctival melanoma","alternate_titles":[],"publication_year":2012,"publication_date":"2012-08-06","ids":{"openalex":"https://openalex.org/W2014909757","doi":"https://doi.org/10.1111/j.1755-3768.2012.3682.x","mag":"2014909757"},"language":"en","primary_location":{"id":"doi:10.1111/j.1755-3768.2012.3682.x","doi":"https://doi.org/10.1111/j.1755-3768.2012.3682.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1755-3768.2012.3682.x","pdf_url":null,"source":{"id":"https://openalex.org/S21165490","display_name":"Acta Ophthalmologica","issn_l":"0001-639X","issn":["0001-639X","1755-375X","1755-3768"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Ophthalmologica","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2014909757"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5070288036","display_name":"Michele C. Madigan","orcid":"https://orcid.org/0000-0003-1053-6979","observed_orcids":["https://orcid.org/0000-0003-1053-6979"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I31746571","display_name":"UNSW Sydney","ror":"https://ror.org/03r8z3t63","country_code":"AU","type":"education","lineage":["https://openalex.org/I31746571"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"MC MADIGAN","raw_affiliation_strings":["Optometry & Vision Science UNSW, Sydney","Save Sight Institute, Uni. Sydney, Sydney"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Optometry & Vision Science UNSW, Sydney","institution_ids":["https://openalex.org/I31746571"]},{"raw_affiliation_string":"Save Sight Institute, Uni. Sydney, Sydney","institution_ids":["https://openalex.org/I129604602"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068630589","display_name":"Luis Munoz\u2010Erazo","orcid":"https://orcid.org/0000-0003-4202-1515","observed_orcids":["https://orcid.org/0000-0003-4202-1515"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"L MUNOZ\u2010ERAZO","raw_affiliation_strings":["Pathology Uni. Sydney, Sydney","Save Sight Institute, Uni. Sydney, Sydney"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pathology Uni. Sydney, Sydney","institution_ids":["https://openalex.org/I129604602"]},{"raw_affiliation_string":"Save Sight Institute, Uni. Sydney, Sydney","institution_ids":["https://openalex.org/I129604602"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5028443232","display_name":"Robert Max Conway","orcid":"https://orcid.org/0000-0003-0264-8794","observed_orcids":["https://orcid.org/0000-0003-0264-8794"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"RM CONWAY","raw_affiliation_strings":["Save Sight Institute, Uni. Sydney, Sydney"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Save Sight Institute, Uni. Sydney, Sydney","institution_ids":["https://openalex.org/I129604602"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4990,"currency":"USD","value_usd":4990},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"90","issue":"s249","first_page":"0","last_page":"0"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11328","display_name":"Ocular Oncology and Treatments","score":0.0035000001080334187,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/valproic-acid","display_name":"valproic acid","score":0.9980000257492065},{"id":"https://openalex.org/keywords/histone-deacetylase-inhibitors","display_name":"histone deacetylase inhibitors","score":0.9769999980926514},{"id":"https://openalex.org/keywords/conjunctival-melanoma","display_name":"conjunctival melanoma","score":0.9850000143051147},{"id":"https://openalex.org/keywords/class-i-hdacs","display_name":"class I HDACs","score":0.7799999713897705},{"id":"https://openalex.org/keywords/class-ii-hdacs","display_name":"class II HDACs","score":0.9850000143051147},{"id":"https://openalex.org/keywords/hdac1","display_name":"HDAC1","score":0.6480000019073486},{"id":"https://openalex.org/keywords/hdac2","display_name":"HDAC2","score":0.859000027179718},{"id":"https://openalex.org/keywords/hdac3","display_name":"HDAC3","score":0.9860000014305115},{"id":"https://openalex.org/keywords/hdac4","display_name":"HDAC4","score":0.984000027179718},{"id":"https://openalex.org/keywords/hdac6","display_name":"HDAC6","score":0.9990000128746033},{"id":"https://openalex.org/keywords/sirt2","display_name":"SIRT2","score":0.9980000257492065},{"id":"https://openalex.org/keywords/melanocytes","display_name":"melanocytes","score":0.8889999985694885},{"id":"https://openalex.org/keywords/cell-proliferation","display_name":"cell proliferation","score":0.6520000100135803},{"id":"https://openalex.org/keywords/cell-cycle-arrest","display_name":"cell cycle arrest","score":0.8450000286102295},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.8299999833106995},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.8479999899864197}],"concepts":[{"id":"https://openalex.org/C23681527","wikidata":"https://www.wikidata.org/wiki/Q18034953","display_name":"HDAC6","level":5,"score":0.6981136202812195},{"id":"https://openalex.org/C2778305200","wikidata":"https://www.wikidata.org/wiki/Q174378","display_name":"Histone deacetylase","level":4,"score":0.6490452289581299},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.5715178847312927},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5146811604499817},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.5010843276977539},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.4951552450656891},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.47500669956207275},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.4605606496334076},{"id":"https://openalex.org/C53227056","wikidata":"https://www.wikidata.org/wiki/Q189152","display_name":"Viability assay","level":3,"score":0.4193839132785797},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.4179081618785858},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4129432439804077},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3647700548171997},{"id":"https://openalex.org/C64927066","wikidata":"https://www.wikidata.org/wiki/Q36293","display_name":"Histone","level":3,"score":0.3171570897102356},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.16824766993522644},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.07810825109481812},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1111/j.1755-3768.2012.3682.x","doi":"https://doi.org/10.1111/j.1755-3768.2012.3682.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1755-3768.2012.3682.x","pdf_url":null,"source":{"id":"https://openalex.org/S21165490","display_name":"Acta Ophthalmologica","issn_l":"0001-639X","issn":["0001-639X","1755-375X","1755-3768"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Ophthalmologica","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1980790672","https://openalex.org/W2046195405","https://openalex.org/W1994582326","https://openalex.org/W2025858622","https://openalex.org/W4381337323","https://openalex.org/W658071017","https://openalex.org/W2557926954","https://openalex.org/W1997392910","https://openalex.org/W2339614040","https://openalex.org/W2044389296"],"abstract_inverted_index":{"Abstract":[0],"Purpose":[1],"To":[2],"investigate":[3],"the":[4,22,227,250],"expression":[5,111,133,230],"of":[6,24,134,162,217,231,252],"histone":[7],"deacetylases":[8],"(HDACs)":[9],"in":[10,114,248],"human":[11],"conjunctival":[12],"melanoma":[13],"(CM)":[14],"cell":[15,35,41,126,219,234],"lines":[16,42],"and":[17,20,30,37,47,60,64,67,69,79,83,98,117,125,139,148,153,168,174,188,212,221,240],"primary":[18,48,253],"melanocytes,":[19,118],"assess":[21],"effects":[23],"VPA,":[25],"a":[26],"broad":[27],"Class":[28,56,62,70],"I":[29,57],"II":[31],"HDAC":[32,110,242],"inhibitor,":[33],"on":[34],"viability":[36],"growth.":[38],"Methods":[39],"CM":[40,115,218],"(CRMM1":[43],"&":[44],"2;":[45],"CM2005.1)":[46],"melanocytes":[49],"were":[50,105],"immunolabelled":[51],"with":[52,77,88,164],"antibodies":[53],"to":[54,94,137,197,207,210,226],"HDACs:":[55],"(HDAC1,":[58],"2":[59,140,152,213],"3),":[61],"IIA":[63],"IIB":[65],"(HDAC4":[66],"HDAC6),":[68],"III":[71],"(SIRT2).":[72],"Antibody":[73],"localisation":[74],"was":[75,90,112,145],"visualised":[76],"immunofluorescence":[78],"confocal":[80],"microscopy.":[81],"Dose\u2010response":[82],"proliferative":[84],"potential":[85],"following":[86],"treatment":[87],"VPA":[89,142,208,215,239],"assessed":[91],"for":[92,119,150,170,186,191,259],"up":[93],"72hrs":[95],"using":[96,238],"MTT":[97],"colony":[99],"assays,":[100],"respectively":[101],"Cell":[102,179],"cycle":[103,180],"dynamics":[104],"also":[106],"assessed.":[107],"Results":[108],"Differential":[109],"observed":[113,228],"cells":[116,129,193,203],"both":[120],"immunolocalisation":[121],"(nuclear":[122],"vs":[123],"cytoplasmic)":[124],"type.":[127],"CM2005.1":[128,154,202],"displayed":[130],"lower":[131],"level":[132],"HDACs":[135,232],"compared":[136,209],"CRMM1":[138,171,187,211],"cells.":[141,214],"IC50":[143],"(72hrs)":[144],"3.75mM,":[146],"5.42mM":[147],"8.33mM":[149],"CRMM1,":[151],"cells,":[155],"respectively.":[156,178],"Colony":[157],"assays":[158],"showed":[159,182],"similar":[160],"patterns":[161],"response,":[163],"surviving":[165],"fractions":[166],"0.2":[167],"0.5":[169],"(VPA":[172,176],"0.3125mM)":[173],"CRMM2":[175,192],"2.5mM)":[177],"analysis":[181],"dose\u2010related":[183],"G1":[184],"block":[185,190],"G2":[189],"at":[194],"24hrs":[195],"(0mM":[196],"1.25mM":[198],"VPA).":[199],"Conclusion":[200],"Overall,":[201],"are":[204],"more":[205],"resistant":[206],"inhibition":[216],"growth":[220,251],"proliferation":[222],"may":[223,244],"be":[224,245],"related":[225],"differential":[229],"between":[233],"lines.":[235],"Combination":[236],"therapies":[237],"other":[241],"inhibitors":[243],"potentially":[246],"useful":[247],"managing":[249],"CM.":[254],"Supported":[255],"by":[256],"Sydney":[257],"Foundation":[258],"Medical":[260],"Research.":[261]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2014909757","counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1}],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2016-06-24T00:00:00"}
